Eksempler på bruk av Nimenrix på Engelsk og deres oversettelse til Norsk
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Please tell your doctor if you have received a previous injection with another meningococcal vaccine than Nimenrix.
The safety and efficacy of Nimenrix in children under 12 months of age has not yet been established.
Nimenrix will only protect against infections caused by the bacteria“Neisseria meningitidis” types A, C, W-135 and Y.
Nimenrix powder and solvent for solution for injection in ampoule Meningococcal group A, C, W-135
Nimenrix must be reconstituted by adding the entire content of the ampoule of solvent to the vial containing the powder.
Nimenrix powder and solvent for solution for injection in pre-filled syringe Meningococcal group A, C, W-135
The syringe provided with Nimenrix might be slightly different(without screw thread)
Nimenrix must be reconstituted by adding the entire content of the pre-filled syringe of solvent to the vial containing the powder.
Nimenrix should be used during pregnancy only when clearly needed,
Nimenrix should be given with caution to individuals with thrombocytopenia
If Nimenrix is to be given at the same time as another injectable vaccine, the vaccines should always be administered at different injection sites.
The sequential administration of Nimenrix one month after a DTaP-HBV-IPV/Hib vaccine resulted in lower GMTs for antibody against groups A,
It concerns American children who are vaccinated with Nimenrix in Europe, and states that they do not need further vaccination with Menveo.
The response to the four meningococcal groups elicited by Nimenrix was either similar
Nimenrix will only confer protection against Neisseria meningitidis group A,
Table 8: Bactericidal antibody responses(rSBA*) to Nimenrix and the ACWY-PS vaccine in children aged 2-10 years 1 month after vaccination study MenACWY-TT-038.
The observed group C booster response with Nimenrix was similar to that observed in subjects primed
Whenever possible, Nimenrix and a TT containing vaccine,
In both adolescents and adults, Nimenrix was demonstrated to be immunologically non-inferior to the ACWY-PS vaccine in terms of vaccine response as defined above Table 11.
Giving Nimenrix with or one month before a TT-containing vaccine in the second year of life does not impair the response to TT